Jon S. Saxe, Director at VistaGen Therapeutics, Inc. (VTGN), bought 20,000 shares at $1.26 ($25K) on 2019-03-13, disclosed to the SEC on 2019-03-14.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.26 | 12,080 | $15K | 60.2% |
| 2 | $1.27 | 7,920 | $10K | 39.8% |
| Total | $1.26 avg | 20,000 | $25K | 100% |
| Filing → |
| DRRX | BUY | 2019-05-28 | $19K | — | Filing → |
| DRRX | BUY | 2019-05-15 | $7K | — | Filing → |
| DRRX | BUY | 2019-05-14 | $55K | — | Filing → |